vorozole has been researched along with triazoles in 113 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.77) | 18.7374 |
1990's | 59 (52.21) | 18.2507 |
2000's | 32 (28.32) | 29.6817 |
2010's | 19 (16.81) | 24.3611 |
2020's | 1 (0.88) | 2.80 |
Authors | Studies |
---|---|
Callens, M; De Coster, R; Janssens, B; Krekels, MD; Van Ginckel, R; Wouters, W | 1 |
Balthazart, J; De Clerck, A; Foidart, A | 1 |
Callens, MJ; De Coster, R; Goeminne, NK; Janssens, BL; Van Ginckel, RF | 1 |
Bowden, CR; Morris, DM; Tuman, RW; Wallace, NH | 1 |
De Coster, R; Janssen, PA; Krekels, MD; Leonaers, A; Van Ginckel, R; Wouters, W | 1 |
Byloos, M; De Coster, R; Goeminne, N; Van Ginckel, R; Vanherck, W; Wouters, W | 1 |
De Coster, R; Dillen, A; Freyne, E; Krekels, MD; Raeymaekers, A; Sanz, G; van Dun, J; Van Gelder, J; Venet, M; Wouters, W | 1 |
Bellens, D; Janssen, PA; Roels, I; Vanden Bossche, H; Willemsens, G | 1 |
Bellens, D; Coene, MC; Janssen, PA; Lauwers, W; Le Jeune, L; Moereels, H; Roels, I; Vanden Bossche, H; Willemsens, G | 1 |
Bowden, CR; Bruynseels, J; De Coster, R; Janssen, PA; Snoeck, E; Tuman, RW; Van Ginckel, R; Van Peer, A; Vanden Bossche, H; Wouters, W | 1 |
Balthazart, J; Evrard, L; Surlemont, C | 1 |
De Coster, R; Krekels, MD; Wouters, W | 1 |
Beerens, D; De Coster, R; Doolaege, R; Gruwez, JA; Van Camp, K; Van Der Pas, H; van Herendael, B; Wouters, W | 1 |
Amery, WK; Bowden, CR; Bruynseels, J; De Coster, R; Janssen, PA; Tuman, RW; Van Rooy, P; Vanderpas, H; Wouters, W | 1 |
Beerens, D; De Coster, R; Freyne, E; Haelterman, C; Krekels, M; Raeymaekers, A; van Dun, J; Van Gelder, J; Venet, M; Wouters, W | 1 |
Amarneh, B; Graham-Lorence, S; Peterson, JA; Simpson, ER; White, RE | 1 |
Balthazart, J; Foidart, A; Harada, N | 2 |
Koymans, LM; Moereels, H; Vanden Bossche, H | 1 |
Balthazart, J; Foidart, A | 1 |
De Coster, R; Snoeck, E; Wouters, W | 1 |
Casebolt, TL; Eto, I; Grubbs, CJ; Kelloff, GJ; Lubet, RA; Steele, VE | 1 |
Bowden, C; De Coster, R; Krekels, M; Van Ginckel, R; Wouters, W | 1 |
Berghman, LR; Decuypere, E; Rombauts, L; Vanmontfort, D; Verhoeven, G | 1 |
Blankenstein, MA; de Frankrijker, E; Donker, TH; Nortier, HW; Thijssen, JH; van der Wall, E | 1 |
Aimar, P; Aste, N; Balthazart, J; Foidart, A; Panzica, GC; Viglietti-Panzica, C | 1 |
Callens, M; De Coster, R; Goeminne, N; Janssens, B; Van Ginckel, R; Wouters, L | 1 |
Bouillon, R; De Coster, R; Van Herck, E; Vanderschueren, D | 1 |
Harada, N; Rissman, EF; Roselli, CE | 1 |
Absil, P; Ball, GF; Balthazart, J; Foidart, A; Harada, N; Houbart, M | 1 |
Ball, GF; Balthazart, J; Castagna, C | 1 |
Bouillon, R; De Coster, R; Ederveen, AG; Nijs, J; van Herck, E; Vanderschueren, D | 1 |
Blankenstein, RA; de Jong, PC; Donker, TH; Maitimu-Smeele, I; Nortier, HW; Slee, PH; Thijssen, JH; van de Ven, J | 1 |
Dowsett, M | 2 |
Spencer, CM; Wiseman, LR | 1 |
Durgam, VR; Tekmal, RR | 1 |
Amoroso, D; Boccardo, F; Brema, F; Cortesi, E; Farris, A; Guida, G; Iacobelli, S; Irtelli, L; Langenaeken, C; Mesiti, M; Mustacchi, G; Nardini, P; Pacini, P | 1 |
Buzdar, AU; Roseman, BJ; Singletary, SE | 1 |
Harada, N; Hatano, O | 1 |
Beex, LV; Houston, SJ; Klijn, J; Langenaeken, C; Nooij, M; Paridaens, R; Piccart, MJ; Roy, JA; Tomiak, E; Van Glabbeke, M; Van Vreckem, A; Vinholes, J | 1 |
Buyse, J; De Coster, R; Decuypere, E; Dewil, E; Mast, J; Veldhuis, JD | 1 |
Harvey, HA | 1 |
Beex, LV; Bonfrer, JM; Bruning, PF; Bruynseels, J; Klijn, JG; Nooij, M; Paridaens, R; Piccart, MJ | 1 |
Huang, ML; Langenaecken, C; Piotrovsky, VK; Van Peer, A | 1 |
Bowden, C; DeCoster, R; Eto, I; Grubbs, CJ; Juliana, MM; Kelloff, GJ; Lubet, RA; Steele, VE; You, M | 1 |
Goss, PE | 1 |
Ambus, U; Bruynseels, J; Clark, RM; Crump, M; De Coster, R; Goss, PE; Tye, LM; Wadden, NA; Walde, D; Weizel, HA | 1 |
Balthazart, J; Castagna, C; Panzica, GC; Russo, C; Tlemçani, O; Viglietti-Panzica, C | 1 |
Bureau, R; Dallemagne, P; Enguehard, C; Galopin, S; Guillon, J; Moslemi, S; Rault S Auvray, P; Séralini, GE; Sonnet, P; Sourdiane, P | 1 |
Iino, Y; Koibuchi, Y; Morishita, Y; Sugamata, N | 1 |
Hoogmartens, J; Jimidar, M; Niemeijer, N; Peeters, R | 1 |
Bruynseels, J; De Coster, R; Goss, PE; Langenaeken, C; Walde, D | 1 |
Hamilton, A; Piccart, M | 1 |
Bergström, M; Bergström-Pettermann, E; Bonasera, TA; Carlström, K; Holte, J; Kirilovas, D; Långström, B; Naessen, T; Simberg, N | 2 |
Goss, PE; Schwartz, LH; Tannock, IF; Winer, EP | 1 |
Blijham, GH; de Jong, PC | 1 |
Coombes, RC; Doody, D; Dowsett, M; English, J; Howes, A; Miall, S | 1 |
Bonneterre, J; Feutrie, ML | 1 |
Grubbs, CJ; Khan, SA; Lubet, RA; Nephew, KP; Osborne, E | 1 |
Harvey, HA; Santen, RJ | 1 |
Bajetta, E; Bichisao, E; Pozzi, P; Toffolatti, L; Zilembo, N | 1 |
Christov, K; Green, A; Grubbs, C; Kelloff, G; Lubet, R; Mehta, RG; Shilkaitis, A | 1 |
Christov, K; Graves, J; Hu, L; Kelloff, G; Lubet, R; Mehta, RR; Shilkaitis, A; Steele, V; You, M | 1 |
Boonen, S; Bouillon, R; de Coster, R; Ederveen, AG; Moermans, K; Van Herck, E; Vandenput, L; Vanderschueren, D; Verstuyf, A | 1 |
Auvray, P; Bichat, F; Genne, P | 1 |
de Crémoux, P | 1 |
Kerbrat, P; Lefeuvre, C | 1 |
Buzdar, A; Howell, A | 1 |
Boeddinghaus, I; Dixon, M; Dowsett, M; Ebbs, S; Gui, G; Harper-Wynne, C; Hills, M; Sacks, N; Salter, J; Smith, I | 1 |
Crist, KA; Grubbs, CJ; Hu, L; Johanning, GL; Lubet, RA; Wang, M; Wang, Y; Yao, R; You, M | 1 |
Knott, KK; Lubet, RA; McGinley, JN; Steele, VE; Thompson, HJ | 1 |
A'Hern, R; Doody, D; Dowsett, M; Harper-Wynne, CL; Hills, MJ; Howes, A; Iqbal, J; Laidlaw, IJ; Lowe, FM; MacNeill, FA; Miall, S; Nasiri, N; Rayter, Z; Sacks, NP; Salter, J; Sauven, P; Shenton, K | 1 |
Bijnens, L; Michiels, B; Molenberghs, G; Thijs, H; Vangeneugden, T | 1 |
Mokbel, K | 1 |
Bergström, M; Bergström-Petterman, E; Carlström, K; Kirilovas, D; Långström, B; Naessen, T | 1 |
Balthazart, J; Evrard, HC | 2 |
Balthazart, J; Cornil, CA; Holloway, KS; Taziaux, M | 1 |
Clemons, MJ; Freedman, OC; Verma, S | 1 |
Baillien, M; Ball, GF; Balthazart, J; Cornil, CA; Taziaux, M | 1 |
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E | 1 |
Diani-Moore, S; Labitzke, E; Papachristou, F; Rifkind, AB | 1 |
Bergström, M; Frändberg, P; Långström, B; Takahashi, K; Vesström, EL; Watanabe, Y | 1 |
Ioannidis, JP; Mauri, D; Pavlidis, N; Polyzos, NP | 1 |
Bergström, M; Bergström-Petterman, E; Carlström, K; Chaika, A; Kirilovas, D; Korniyenko, S; Mogilevkina, I; Naessen, T; Nosenko, J; Yakovets, A | 1 |
Bergström, M; Hallberg, M; Långström, B; Magnusson, K; Nyberg, F; Takahashi, K; Watanabe, Y | 1 |
Bergström, M; Långström, B; Takahashi, K; Tamura, Y; Watanabe, Y | 1 |
Bode, AM; Christov, K; Ericson, ME; Grubbs, CJ; Juliana, MM; Lubet, RA; Steele, VE; Szabo, E | 1 |
Lenie, S; Smitz, J | 1 |
Alexoff, DL; Biegon, A; Carter, P; Ehrlich, CW; Fowler, JS; Hooker, JM; Katsamanis, ZE; Kim, SW; King, P; Muench, L; Shea, C; Xu, Y | 1 |
Alonso, A; Laenen, A | 1 |
Biegon, A; Fowler, JS; Hooker, JM; Kim, SW; Logan, J; Muench, L | 1 |
Jiao, J; Liao, Q; Xiang, H | 1 |
Alexoff, DL; Biegon, A; Carter, P; Fowler, JS; Hubbard, B; Jayne, M; Kim, SW; King, P; Logan, J; Muench, L; Pareto, D; Schlyer, D; Shea, C; Telang, F; Wang, GJ; Xu, Y | 1 |
Doi, H; Hiramatsu, T; Hosoya, A; Hosoya, T; Nagata, H; Onoe, H; Onoe, K; Takahashi, K; Wada, Y; Watanabe, Y; Yamagishi, G | 1 |
Bergström, M; Doi, H; Hosoya, T; Långström, B; Mizuma, H; Nagata, H; Onoe, H; Onoe, K; Takahashi, K; Takashima, T; Tamura, Y; Wada, Y; Watanabe, Y; Yamagishi, G; Yamanaka, H; Yokoyama, C | 1 |
Mahon, MF; Potter, BV; Purohit, A; Thomas, MP; Woo, LW; Wood, PM | 1 |
A'Hern, R; Anderson, H; Bliss, J; Dowsett, M; Dunbier, A; Evans, A; Ghazoui, Z; Iskender, A; Johnson, L; Pinhel, I; Robertson, J; Robison, L; Salter, J; Skene, T; Smith, I; Wilcox, M | 1 |
Akazawa, KH; Cui, Y; Doi, H; Hosoya, T; Kataoka, Y; Nagata, H; Ozawa, M; Takahashi, K; Takashima, T; Wada, Y; Watanabe, Y | 1 |
Ball, GF; Balthazart, J; Cornil, CA; de Meaultsart, CC | 1 |
Hosoya, T; Kusuhara, H; Miyajima, M; Sugiyama, Y; Takahashi, K; Takashima, T; Watanabe, Y | 1 |
Garbow, JR; He, J; Higashikubo, R; Jones, LA; Lubet, RA; Mach, RH; Rowland, D; Shoghi, KI; Su, Y; Tu, Z; Wheeler, KT; Xu, J; Yan, Y; You, M | 1 |
Doi, H; Hiramatsu, T; Hosoya, T; Li, XL; Nagata, H; Onoe, H; Onoe, K; Suzuki, M; Takahashi, K; Takashima, T; Wada, Y; Watanabe, Y | 1 |
Biegon, A; Fowler, JS; Kim, SW; Logan, J; Pareto, D; Telang, F; Wang, GJ | 1 |
Alexoff, DL; Biegon, A; Fowler, JS; Kim, SW; Logan, J; Pareto, D; Schlyer, D; Wang, GJ | 1 |
Ball, GF; Balthazart, J; Cornil, CA; Seredynski, AL | 1 |
Ball, GF; Balthazart, J; Cornil, CA; de Bournonville, C | 1 |
Bode, A; Grubbs, CJ; Juliana, MM; Lubet, RA; Moeinpour, F; Steele, VE | 1 |
Ball, GF; Balthazart, J; Cornil, CA; de Bournonville, MP; Vandries, LM | 1 |
Airola, K; Biegon, A; Bonilla, P; Cohen, J; Dhawan, J; Franceschi, D; Pareto, D; Shroyer, KR; Tahmi, M | 1 |
22 review(s) available for vorozole and triazoles
Article | Year |
---|---|
From 14 alpha-demethylase inhibitors in fungal cells to androgen and oestrogen biosynthesis inhibitors in mammalian cells.
Topics: Androgen Antagonists; Animals; Antifungal Agents; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estrogen Antagonists; Humans; Imidazoles; Ketoconazole; Oxidoreductases; Sterol 14-Demethylase; Triazoles | 1990 |
New non-steroidal aromatase inhibitors: focus on R76713.
Topics: Animals; Aromatase Inhibitors; Female; Humans; Male; Pregnancy; Triazoles | 1990 |
Vorozole, a specific non-steroidal aromatase inhibitor.
Topics: Animals; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estradiol; Female; Hormones; Humans; In Vitro Techniques; Male; Mammary Neoplasms, Experimental; Triazoles | 1994 |
Vorozole.
Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles | 1997 |
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles | 1997 |
Emerging role of aromatase inhibitors in the treatment of breast cancer.
Topics: Aged; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Triazoles | 1998 |
Theoretical considerations for the ideal aromatase inhibitor.
Topics: Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles | 1998 |
Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor.
Topics: Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Enzyme Inhibitors; Humans; Neoplasms, Hormone-Dependent; Randomized Controlled Trials as Topic; Triazoles | 1998 |
The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Belgium; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Female; Humans; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Severity of Illness Index; Survival Rate; Tamoxifen; Treatment Outcome; Triazoles | 1999 |
New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Triazoles | 1999 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrone; Female; Humans; Letrozole; Nitriles; Triazoles | 1999 |
Use of aromatase inhibitors in breast carcinoma.
Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles | 1999 |
Steroidal aromatase inhibitors in elderly patients.
Topics: Aged; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles | 2000 |
[Preclinical evaluation of aromatase inhibitors antitumor activity].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Models, Animal; Nitriles; Rats; Structure-Activity Relationship; Triazoles | 2000 |
[Aromatase inhibitors: pharmacological aspects].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2000 |
[Aromatase inhibitors: a review of clinical trials].
Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Triazoles | 2000 |
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting | 2001 |
The evolving role of aromatase inhibitors in breast cancer.
Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Humans; Letrozole; Nitriles; Triazoles | 2002 |
Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Evidence-Based Medicine; Female; Humans; Letrozole; Mastectomy, Segmental; Neoadjuvant Therapy; Nitriles; Randomized Controlled Trials as Topic; Receptors, Estrogen; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles | 2005 |
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles | 2005 |
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Topics: Adult; Aged; Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2006 |
Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Chromones; Coumarins; Female; Flavonoids; Humans; Letrozole; Nitriles; Receptors, Estrogen; Sulfonamides; Triazoles | 2010 |
10 trial(s) available for vorozole and triazoles
Article | Year |
---|---|
Aromatase inhibition by R 76713: experimental and clinical pharmacology.
Topics: Adult; Aldosterone; Animals; Aromatase Inhibitors; Diet, Sodium-Restricted; Estradiol; Female; Humans; Macaca fascicularis; Male; Rats; Rats, Inbred Strains; Reference Values; Renin; Triazoles | 1989 |
Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women.
Topics: Aged; Androstenedione; Aromatase Inhibitors; Carbon Radioisotopes; Double-Blind Method; Estrone; Female; Humans; Postmenopause; Triazoles; Tritium | 1993 |
Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole.
Topics: Aged; Antineoplastic Agents; Aromatase; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Middle Aged; Triazoles | 1997 |
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study.
Topics: Aged; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrone; Female; Humans; Middle Aged; Postmenopause; Triazoles | 1997 |
Vorozole (Rivizor): an active and well tolerated new aromatase inhibitor for the treatment of advanced breast cancer patients with prior tamoxifen exposure. Investigational Drug Branch of the European Organization for Research and Treatment of Cancer (EOR
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Female; Hot Flashes; Humans; Middle Aged; Nausea; Tamoxifen; Triazoles | 1998 |
Vorozole (R83842) in the treatment of postmenopausal advanced breast cancer: relationship of serum levels of vorozole and clinical results (a study of the EORTC Breast Cancer Cooperative Group).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Hormones; Humans; Middle Aged; Postmenopause; Statistics as Topic; Treatment Outcome; Triazoles | 1998 |
Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Topics: Aged; Aged, 80 and over; Aldosterone; Androgens; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles | 1995 |
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Postmenopause; Triazoles | 1999 |
Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer.
Topics: Adult; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Goserelin; Humans; Middle Aged; Ovary; Postmenopause; Premenopause; Triazoles | 1999 |
Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Enzyme Inhibitors; Female; Follicle Stimulating Hormone; Humans; Ki-67 Antigen; Luteinizing Hormone; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles | 2002 |
81 other study(ies) available for vorozole and triazoles
Article | Year |
---|---|
Aromatase inhibition by R 83 842, the dextro isomer of R 76 713, in JEG-3 choriocarcinoma grown in ovariectomized nude mice.
Topics: Animals; Aromatase Inhibitors; Cell Line; Choriocarcinoma; Female; Humans; Isomerism; Mice; Mice, Nude; Neoplasm Transplantation; Pregnancy; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured; Uterine Neoplasms | 1992 |
Behavioral demasculinization of female quail is induced by estrogens: studies with the new aromatase inhibitor, R76713.
Topics: Animals; Aromatase Inhibitors; Copulation; Coturnix; Dose-Response Relationship, Drug; Estradiol; Female; Male; Sex Differentiation; Sexual Behavior, Animal; Sexual Maturation; Testosterone; Triazoles | 1992 |
Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Aromatase Inhibitors; Drug Administration Schedule; Drug Screening Assays, Antitumor; Estradiol; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Ovariectomy; Random Allocation; Rats; Rats, Inbred Strains; Triazoles | 1992 |
Inhibition of peripheral aromatization in the male cynomolgus monkey by a novel nonsteroidal aromatase inhibitor (R 76713).
Topics: Androstenedione; Animals; Aromatase Inhibitors; Dose-Response Relationship, Drug; Estrone; Injections, Intravenous; Macaca fascicularis; Male; Pharmaceutical Vehicles; Triazoles | 1991 |
Aromatase in the human choriocarcinoma JEG-3: inhibition by R 76 713 in cultured cells and in tumors grown in nude mice.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Binding, Competitive; Choriocarcinoma; Female; Humans; Kinetics; Mice; Mice, Nude; Substrate Specificity; Testosterone; Triazoles; Tumor Cells, Cultured | 1991 |
Endocrine and antitumoral effects of R76713 in rats.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Estradiol; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Ovariectomy; Ovary; Progesterone; Rats; Rats, Inbred Strains; Triazoles; Uterus | 1990 |
Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Aromatase Inhibitors; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Equine; Granulosa Cells; In Vitro Techniques; Male; Ovary; Rats; Stereoisomerism; Steroid Hydroxylases; Steroids; Testis; Testosterone; Triazoles | 1990 |
R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis.
Topics: Adrenal Glands; Androgens; Androstenedione; Animals; Aromatase Inhibitors; Cattle; Cytochrome P-450 Enzyme Inhibitors; Estrogens; Female; Male; Microsomes; Placenta; Rabbits; Rats; Spectrophotometry; Stereoisomerism; Swine; Testis; Triazoles | 1990 |
Effects of the nonsteroidal inhibitor R76713 on testosterone-induced sexual behavior in the Japanese quail (Coturnix coturnix japonica).
Topics: Animals; Aromatase Inhibitors; Brain Mapping; Copulation; Coturnix; Estradiol; Male; Preoptic Area; Sexual Behavior, Animal; Testosterone; Triazoles | 1990 |
Aromatase inhibition by R 76 713: a kinetic analysis in rat ovarian homogenates.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Female; Kinetics; Ovary; Rats; Rats, Inbred Strains; Testosterone; Triazoles | 1990 |
Potency and selectivity of the aromatase inhibitor R 76,713. A study in human ovarian, adipose stromal, testicular and adrenal cells.
Topics: Adipose Tissue; Adrenal Glands; Aromatase Inhibitors; Binding, Competitive; Cells, Cultured; Female; Humans; Kinetics; Male; Ovary; Steroids; Testis; Triazoles | 1990 |
R 76713, a new specific non-steroidal aromatase inhibitor.
Topics: Adrenal Glands; Aminoglutethimide; Animals; Aromatase Inhibitors; Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Female; Granulosa Cells; Male; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Testis; Triazoles | 1989 |
A three-dimensional model of aromatase cytochrome P450.
Topics: Amino Acid Sequence; Aromatase; Bacterial Proteins; Camphor 5-Monooxygenase; Catalysis; Computer Simulation; Conserved Sequence; Cytochrome P-450 Enzyme System; Mixed Function Oxygenases; Models, Chemical; Models, Molecular; Molecular Sequence Data; NADPH-Ferrihemoprotein Reductase; Sequence Alignment; Sequence Homology, Amino Acid; Triazoles | 1995 |
Aromatase-immunoreactive cells are present in mouse brain areas that are known to express high levels of aromatase activity.
Topics: Animals; Aromatase; Brain; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Triazoles | 1995 |
A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 aromatase).
Topics: Amino Acid Sequence; Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Humans; In Vitro Techniques; Models, Molecular; Molecular Sequence Data; Protein Structure, Secondary; Protein Structure, Tertiary; Sequence Alignment; Triazoles | 1995 |
Sexual differentiation of brain and behavior in quail and zebra finches: studies with a new aromatase inhibitor, R76713.
Topics: Animals; Aromatase Inhibitors; Behavior, Animal; Birds; Coturnix; Female; Male; Rodentia; Sex Differentiation; Triazoles; Vocalization, Animal | 1995 |
Effects of steroidal and non steroidal aromatase inhibitors on sexual behavior and aromatase-immunoreactive cells and fibers in the quail brain.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Brain; Coturnix; Drug Implants; Immunoenzyme Techniques; Male; Nerve Fibers; Sexual Behavior, Animal; Testosterone; Triazoles | 1994 |
Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats.
Topics: Adenocarcinoma; Aminoglutethimide; Androstenedione; Animals; Anticarcinogenic Agents; Aromatase Inhibitors; Drug Screening Assays, Antitumor; Estrus; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Triazoles | 1994 |
Pharmacology of vorozole.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Aromatase Inhibitors; Cell Division; Cells, Cultured; Choriocarcinoma; Chorionic Gonadotropin; Corticosterone; Estradiol; Female; Follicle Stimulating Hormone; Granulosa Cells; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organ Size; Pregnancy; Rats; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Testis; Testosterone; Triazoles; Uterine Neoplasms; Uterus | 1993 |
Changes in immunoreactive FSH and inhibin in developing chicken embryos and the effects of estradiol and the aromatase inhibitor R76713.
Topics: Animals; Aromatase Inhibitors; Chick Embryo; Estradiol; Female; Follicle Stimulating Hormone; Inhibins; Male; Time Factors; Triazoles | 1993 |
Implication of testosterone metabolism in the control of the sexually dimorphic nucleus of the quail preoptic area.
Topics: Animals; Aromatase Inhibitors; Coturnix; Female; Image Processing, Computer-Assisted; Male; Neurons; Orchiectomy; Preoptic Area; Sex Characteristics; Sexual Behavior, Animal; Testosterone; Triazoles | 1993 |
Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinogens; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Ovariectomy; Progesterone; Rats; Rats, Sprague-Dawley; Tamoxifen; Triazoles | 1996 |
Aromatization of androgens is important for skeletal maintenance of aged male rats.
Topics: Absorptiometry, Photon; Aging; Amino Acids; Analysis of Variance; Androgens; Animals; Aromatase Inhibitors; Bone Density; Bone Development; Bone Resorption; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrogens; Femur; Lumbar Vertebrae; Male; Orchiectomy; Osteocalcin; Osteoporosis; Rats; Rats, Wistar; Triazoles | 1996 |
Effect of vorozole, an aromatase enzyme inhibitor, on sexual behavior, aromatase activity and neural immunoreactivity.
Topics: Animals; Aromatase Inhibitors; Brain; Brain Chemistry; Estrogens; Female; Immunohistochemistry; Male; Neurons; Sex Characteristics; Sexual Behavior, Animal; Shrews; Triazoles | 1996 |
Distribution of aromatase-immunoreactive cells in the forebrain of zebra finches (Taeniopygia guttata): implications for the neural action of steroids and nuclear definition in the avian hypothalamus.
Topics: Animals; Antibody Specificity; Aromatase; Aromatase Inhibitors; Biomarkers; Birds; Brain Chemistry; Enzyme Inhibitors; Immunohistochemistry; Male; Neurons; Paraventricular Hypothalamic Nucleus; Preoptic Area; Prosencephalon; Sex Factors; Steroids; Telencephalon; Triazoles; Vasotocin | 1996 |
Aromatase inhibition blocks the activation and sexual differentiation of appetitive male sexual behavior in Japanese quail.
Topics: Animals; Appetitive Behavior; Aromatase; Aromatase Inhibitors; Copulation; Coturnix; Enzyme Inhibitors; Estrogens; Female; Libido; Male; Sex Differentiation; Sexual Behavior, Animal; Testosterone; Triazoles | 1997 |
Clinical development plan: (+)-vorozole.
Topics: Animals; Anticarcinogenic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Drug Approval; Enzyme Inhibitors; Estradiol; Female; Humans; Male; Neoplasms, Experimental; Rats; Research Design; Triazoles | 1996 |
Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats.
Topics: Absorptiometry, Photon; Aging; Animals; Aromatase Inhibitors; Body Weight; Bone Density; Bone Development; Bone Remodeling; Enzyme Inhibitors; Femur; Insulin-Like Growth Factor I; Male; Orchiectomy; Rats; Rats, Wistar; Reference Values; Triazoles | 1997 |
Aromatase inhibitors come of age.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Nitriles; Triazoles | 1997 |
A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Analysis of Variance; Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fadrozole; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Ovariectomy; Postmenopause; Triazoles; Tumor Cells, Cultured | 1997 |
Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Carcinoma, Hepatocellular; Choriocarcinoma; Colforsin; Cycloheximide; Enzyme-Linked Immunosorbent Assay; Fadrozole; Humans; Liver Neoplasms; Neoplasm Proteins; Protein Synthesis Inhibitors; RNA, Messenger; Triazoles; Tumor Cells, Cultured | 1998 |
In ovo treatment with an aromatase inhibitor masculinizes postnatal hormone levels, abdominal fat pad content, and GH pulsatility in broiler chickens.
Topics: Adipose Tissue; Analysis of Variance; Animals; Aromatase Inhibitors; Body Composition; Body Weight; Chick Embryo; Chickens; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Female; Growth Hormone; Injections; Male; Random Allocation; Sex Characteristics; Testosterone; Thyroxine; Time Factors; Triazoles; Triiodothyronine | 1998 |
Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Body Height; Body Weight; Breast Neoplasms; Female; Humans; Male; Middle Aged; Population; Regression Analysis; Sex Factors; Triazoles | 1998 |
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Carcinogens; Drug Administration Schedule; Drug Screening Assays, Antitumor; Estradiol; Estrus; Female; Genes, ras; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Testosterone; Triazoles | 1998 |
Organizational effects of estrogens on brain vasotocin and sexual behavior in quail.
Topics: Analysis of Variance; Animals; Aromatase Inhibitors; Body Weight; Brain Chemistry; Cloaca; Coturnix; Embryo, Nonmammalian; Estradiol; Female; Immunohistochemistry; Male; Neurons; Preoptic Area; Sex Characteristics; Sexual Behavior, Animal; Testosterone; Triazoles; Vasotocin | 1998 |
Design and synthesis of a new type of non steroidal human aromatase inhibitors.
Topics: Aromatase Inhibitors; Drug Design; Enzyme Inhibitors; Fadrozole; Female; Humans; Indicators and Reagents; Indolizines; Microsomes; Placenta; Pregnancy; Pyridines; Structure-Activity Relationship; Triazoles | 1998 |
A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antineoplastic Agents; Aromatase Inhibitors; Enzyme Inhibitors; Female; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Rats; Triazoles | 1999 |
Robustness testing of a liquid chromatography method for the determination of vorozole and its related compounds in oral tablets.
Topics: Antineoplastic Agents; Chromatography, Liquid; Enzyme Inhibitors; Sensitivity and Specificity; Tablets; Triazoles | 1998 |
Rivizor--a new third-generation aromatase inhibitor for the treatment of advanced breast cancer after tamoxifen failure.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoembryonic Antigen; Disease Progression; Enzyme Inhibitors; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Tamoxifen; Time Factors; Treatment Failure; Treatment Outcome; Triazoles | 1999 |
In vitro evaluation of aromatase enzyme in granulosa cells using a [11C]vorozole binding assay.
Topics: Aromatase; Aromatase Inhibitors; Carbon Radioisotopes; Enzyme Inhibitors; Female; Granulosa Cells; Humans; Triazoles | 1999 |
Effects of oral administration of tamoxifen, toremifene, dehydroepiandrosterone, and vorozole on uterine histomorphology in the rat.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Dehydroepiandrosterone; Female; Mammary Neoplasms, Animal; Rats; Rats, Sprague-Dawley; Tamoxifen; Toremifene; Triazoles; Uterus | 2000 |
Cellular responses of mammary carcinomas to aromatase inhibitors: effects of vorozole.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aromatase Inhibitors; Biomarkers, Tumor; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Female; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Triazoles | 2000 |
Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis.
Topics: Animals; Apoptosis; Aromatase Inhibitors; bcl-2-Associated X Protein; Carcinoma; Epithelial Cells; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triazoles | 2000 |
Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model.
Topics: Aging; Animals; Aromatase Inhibitors; Body Weight; Bone and Bones; Bone Density; Bone Remodeling; Enzyme Inhibitors; Estradiol; Estrogens; Male; Models, Animal; Rats; Rats, Wistar; Triazoles | 2000 |
HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Female; Gene Amplification; Humans; Immunohistochemistry; Ki-67 Antigen; Multicenter Studies as Topic; Nitriles; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Triazoles | 2001 |
Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Aromatase; Aromatase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization; Mammary Neoplasms, Experimental; Methylnitrosourea; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Sequence Homology, Amino Acid; Triazoles; Up-Regulation | 2001 |
Effect of the aromatase inhibitor vorozole on estrogen and progesterone receptor content of rat mammary carcinomas induced by 1-methyl-1-nitrosourea.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Diet; Drug Administration Schedule; Epithelial Cells; Female; Immunoenzyme Techniques; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Triazoles | 2001 |
Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-out.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Humans; Longitudinal Studies; Models, Statistical; Neoplasms, Hormone-Dependent; Patient Dropouts; Quality of Life; Triazoles | 2002 |
Effects of androgens on aromatase activity and 11C-vorozole binding in granulosa cells in vitro.
Topics: Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Binding, Competitive; Dihydrotestosterone; Enzyme Inhibitors; Etiocholanolone; Female; Granulosa Cells; Humans; Statistics, Nonparametric; Testosterone; Triazoles | 2003 |
Characterization of [11C]vorozole binding in ovarian tissue in rats throughout estrous cycle in association with conversion of androgens to estrogens in vivo and in vitro.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Binding Sites; Enzyme Inhibitors; Estradiol; Estrous Cycle; Estrus; Female; In Vitro Techniques; Luteinizing Hormone; Ovary; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Triazoles | 2003 |
Aromatization of androgens into estrogens reduces response latency to a noxious thermal stimulus in male quail.
Topics: Analysis of Variance; Animals; Aromatase; Aromatase Inhibitors; Avoidance Learning; Coturnix; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Hot Temperature; Male; Perception; Random Allocation; Reaction Time; Tamoxifen; Testosterone; Triazoles | 2004 |
Rapid regulation of pain by estrogens synthesized in spinal dorsal horn neurons.
Topics: Animals; Aromatase Inhibitors; Behavior, Animal; Catheterization; Cerebral Ventricles; Coturnix; Enzyme Inhibitors; Estradiol; Estrogens; Hot Temperature; Injections, Spinal; Kinetics; Male; Orchiectomy; Pain; Posterior Horn Cells; Testosterone; Triazoles | 2004 |
The effects of aromatase inhibition on testosterone-dependent conditioned rhythmic cloacal sphincter movements in male Japanese quail.
Topics: Animals; Aromatase Inhibitors; Body Weight; Cloaca; Conditioning, Operant; Coturnix; Defecation; Enzyme Inhibitors; Female; Male; Movement; Testosterone; Triazoles | 2004 |
Rapid effects of aromatase inhibition on male reproductive behaviors in Japanese quail.
Topics: Animals; Appetitive Behavior; Aromatase; Aromatase Inhibitors; Cloaca; Consummatory Behavior; Coturnix; Estradiol; Hypothalamus; In Vitro Techniques; Male; Motor Activity; Orchiectomy; Preoptic Area; Sexual Behavior, Animal; Social Environment; Testosterone; Triazoles | 2006 |
Induction of CYP1A and cyp2-mediated arachidonic acid epoxygenation and suppression of 20-hydroxyeicosatetraenoic acid by imidazole derivatives including the aromatase inhibitor vorozole.
Topics: Animals; Arachidonic Acids; Aromatase Inhibitors; Benzimidazoles; Cell Line, Tumor; Chick Embryo; Cytochrome P-450 Enzyme System; Enzyme Induction; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Mice; Microsomes, Liver; Phenobarbital; Polychlorinated Dibenzodioxins; RNA, Messenger; Triazoles | 2006 |
Imaging of aromatase distribution in rat and rhesus monkey brains with [11C]vorozole.
Topics: Animals; Aromatase; Brain; Carbon Radioisotopes; Female; Macaca mulatta; Male; Metabolic Clearance Rate; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Species Specificity; Tissue Distribution; Triazoles | 2006 |
Granulosa cell aromatase enzyme activity: effects of follicular fluid from patients with polycystic ovary syndrome, using aromatase conversion and [11C]vorozole-binding assays.
Topics: Aromatase; Diagnostic Techniques, Radioisotope; Estrogens; Female; Follicular Fluid; Granulosa Cells; Humans; Polycystic Ovary Syndrome; Substrate Specificity; Triazoles | 2006 |
Increase in [11C]vorozole binding to aromatase in the hypothalamus in rats treated with anabolic androgenic steroids.
Topics: Androgens; Animals; Aromatase; Aromatase Inhibitors; Autoradiography; Carbon Radioisotopes; Disease Models, Animal; Hypothalamus; Male; Nandrolone; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Septal Nuclei; Substance-Related Disorders; Triazoles | 2007 |
Alteration in [11C]vorozole binding to aromatase in neuronal cells of rat brain induced by anabolic androgenic steroids and flutamide.
Topics: Amygdala; Androgen Antagonists; Androgens; Animals; Aromatase; Aromatase Inhibitors; Binding, Competitive; Brain; Brain Mapping; Carbon Radioisotopes; Flutamide; Male; Neurons; Positron-Emission Tomography; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Septal Nuclei; Triazoles; Up-Regulation | 2008 |
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bexarotene; Biomarkers, Tumor; Carcinogens; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Therapy, Combination; ErbB Receptors; Female; Gefitinib; Immunoenzyme Techniques; Mammary Neoplasms, Experimental; Methylnitrosourea; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Triazoles | 2008 |
Steroidogenesis-disrupting compounds can be effectively studied for major fertility-related endpoints using in vitro cultured mouse follicles.
Topics: Aminoglutethimide; Animals; Animals, Newborn; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Endocrine Disruptors; Female; In Vitro Techniques; Ketoconazole; Mice; Mice, Inbred Strains; Ovarian Follicle; Sensitivity and Specificity; Steroids; Toxicity Tests; Triazoles | 2009 |
Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase.
Topics: Alkylation; Animals; Aromatase; Brain; Chromatography, High Pressure Liquid; Female; Hydrocarbons, Iodinated; Magnetic Resonance Spectroscopy; Papio; Positron-Emission Tomography; Radioactive Tracers; Stereoisomerism; Time Factors; Triazoles | 2009 |
The Functional Living Index-Cancer: estimating its reliability based on clinical trial data.
Topics: Aged; Antineoplastic Agents; Belgium; Breast Neoplasms; Discriminant Analysis; Female; Humans; Longitudinal Studies; Megestrol Acetate; Middle Aged; Patient Participation; Psychometrics; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Triazoles | 2010 |
Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons.
Topics: Animals; Aromatase Inhibitors; Brain; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Injections, Intravenous; Magnetic Resonance Imaging; Nicotine; Nicotinic Agonists; Papio; Positron-Emission Tomography; Triazoles | 2010 |
Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole.
Topics: Adult; Aromatase; Aromatase Inhibitors; Brain; Brain Mapping; Female; Humans; Male; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Tissue Distribution; Triazoles; Young Adult | 2010 |
Practical synthesis of precursor of [N-methyl-11C]vorozole, an efficient PET tracer targeting aromatase in the brain.
Topics: Animals; Aromatase; Aromatase Inhibitors; Brain; Brain Chemistry; Macaca mulatta; Male; Positron-Emission Tomography; Stereoisomerism; Triazoles | 2011 |
Increase in hypothalamic aromatase in macaque monkeys treated with anabolic-androgenic steroids: PET study with [11C]vorozole.
Topics: Anabolic Agents; Androgens; Animals; Aromatase; Carbon Radioisotopes; Hypothalamus; Macaca mulatta; Male; Positron-Emission Tomography; Triazoles | 2011 |
Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.
Topics: Aromatase; Aromatase Inhibitors; Binding Sites; Catalytic Domain; Cell Line, Tumor; Computer Simulation; Crystallography, X-Ray; Enzyme Activation; Humans; Letrozole; Nitriles; Stereoisomerism; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids; Triazoles | 2011 |
Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Ki-67 Antigen; Lapatinib; Molecular Targeted Therapy; Multicenter Studies as Topic; Neoadjuvant Therapy; Nitriles; Predictive Value of Tests; Preoperative Period; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Triazoles | 2011 |
PET of aromatase in gastric parietal cells using 11C-vorozole.
Topics: Animals; Aromatase; Autoradiography; Carbon Radioisotopes; Fatigue; Female; Immunohistochemistry; Male; Parietal Cells, Gastric; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Triazoles; Whole Body Imaging | 2011 |
Distinct neuroendocrine mechanisms control neural activity underlying sex differences in sexual motivation and performance.
Topics: Animals; Appetitive Behavior; Aromatase Inhibitors; Brain; Cloaca; Coturnix; Estrogens; Female; Gene Expression; Neurons; Neurosecretory Systems; Proto-Oncogene Proteins c-fos; Sex Characteristics; Sexual Behavior, Animal; Testosterone; Triazoles | 2013 |
Investigation of the effect of active efflux at the blood-brain barrier on the distribution of nonsteroidal aromatase inhibitors in the central nervous system.
Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; ATP Binding Cassette Transporter, Subfamily B; Blood-Brain Barrier; Brain; Cell Line; Humans; Letrozole; Male; Mice; Nitriles; Triazoles | 2013 |
Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1.
Topics: Alkylating Agents; Animals; Anticarcinogenic Agents; Apoptosis; Benzamides; Bexarotene; Blotting, Western; Cell Proliferation; Female; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Ligands; Mammary Neoplasms, Animal; Methylnitrosourea; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Receptors, sigma; Tetrahydronaphthalenes; Triazoles; Tumor Cells, Cultured | 2013 |
11C-cetrozole: an improved C-11C-methylated PET probe for aromatase imaging in the brain.
Topics: Aniline Compounds; Animals; Aromatase; Aromatase Inhibitors; Autoradiography; Brain; Carbon Radioisotopes; Female; Inhibitory Concentration 50; Macaca mulatta; Male; Methylation; Positron-Emission Tomography; Protein Binding; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triazoles | 2014 |
Kinetic analysis of [11C]vorozole binding in the human brain with positron emission tomography.
Topics: Adult; Aged; Aromatase Inhibitors; Carbon Radioisotopes; Cerebellum; Female; Humans; Letrozole; Male; Middle Aged; Nitriles; Positron-Emission Tomography; Thalamus; Tissue Distribution; Triazoles; Young Adult | 2014 |
Aromatase imaging with [N-methyl-11C]vorozole PET in healthy men and women.
Topics: Adult; Age Factors; Aged; Aromatase; Aromatase Inhibitors; Diagnostic Imaging; Female; Healthy Volunteers; Humans; Letrozole; Liver; Male; Middle Aged; Nitriles; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Reproducibility of Results; Sex Factors; Software; Triazoles; Whole-Body Irradiation; Young Adult | 2015 |
Estrogen Receptor β Activation Rapidly Modulates Male Sexual Motivation through the Transactivation of Metabotropic Glutamate Receptor 1a.
Topics: Analysis of Variance; Animals; Aromatase; Coturnix; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Receptor beta; Excitatory Amino Acid Agents; Hormones; Male; Motivation; Nitriles; Propionates; Receptors, Metabotropic Glutamate; Sexual Behavior, Animal; Time Factors; Triazoles | 2015 |
Non-ovarian aromatization is required to activate female sexual motivation in testosterone-treated ovariectomized quail.
Topics: Animals; Aromatase; Aromatase Inhibitors; Coturnix; Estradiol; Female; Male; Motivation; Ovariectomy; Ovary; Quail; Sexual Behavior, Animal; Testosterone; Triazoles | 2016 |
Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer models.
Topics: Animals; Disease Models, Animal; Drug Administration Schedule; ErbB Receptors; Female; Gefitinib; Heterocyclic Compounds, 3-Ring; Lapatinib; Male; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Triazoles | 2018 |
Site-specific effects of aromatase inhibition on the activation of male sexual behavior in male Japanese quail (Coturnix japonica).
Topics: Animals; Appetitive Behavior; Aromatase; Aromatase Inhibitors; Brain Mapping; Consummatory Behavior; Coturnix; Female; Male; Organ Specificity; Preoptic Area; Septal Nuclei; Sex Factors; Sexual Behavior, Animal; Testosterone; Triazoles; Ventromedial Hypothalamic Nucleus | 2019 |
Initial Studies with
Topics: Aged; Aromatase; Breast Neoplasms; Carbon Radioisotopes; Female; Humans; Immunohistochemistry; Middle Aged; Positron-Emission Tomography; Triazoles | 2020 |